Our US Management team has more than 100 years of combined experience in life science.
Chief Executive Officer – John Phillips
John has over 30 years of life science experience in commercialization, strategy and portfolio management with Roche, Bayer, Bristol Myers Squibb and Johnson & Johnson. In addition, he has consulted to both pharmaceutical and medical technology companies with Cap Gemini, PwC, Deloitte and IQVIA. Former Managing Director, Deloitte Advisory, National Capital Efficiency Practice and former Senior Principal, IQVIA, Corporate Strategy & Portfolio Analytics. John received a Bachelor of Science in Chemistry from the State University of New York at Buffalo, MBA from The Whitman School at Syracuse University, and Executive Certificate from The Wharton School at The University of Pennsylvania
Founder & Chief Technology Officer – Srikanth Jadcherla Jadcherla
Srikanth (Sree) Jadcherla is a mobile technology guru and serial entrepreneur. Most of the mobile platforms in the world use his work done at Intel as a platform architect and later at Archpro, an Intel Capital company, that successfully exited Synopsys. Sree is a winner of the Intel Achievement Award and the author of 15 patents. He is a graduate of IIT Madras (EE) and UC, Santa Barbara (MS-CS)
Chief Medical Officer – Gerard Abate, MD
Clinical cardiologist, with over 30 years of practice and industry experience. He has had a distinguished career in pharma, diagnostics and device industries. He has played a key role in a number of device and drug launches. He held positions as Chief Clinical Officer for Atherotech Diagnostics and then Executive Director of Medical Affairs for Quest Diagnostics. He has consulted in the device and pharma industry since 2018. He has served as an advisor for iMedrix, Inc for 4 years and now serves as Chief Medical Officer for iMedrix Diagnostics
General Counsel & Chief Administrative Officer – Jeffrey Wawrzyniak, Esq.
Jeff has over 33 years of legal experience with law firms as well as in-house with public, privately held, PE backed, pre-IPO and start-up ventures in a variety of manufacturing and technology businesses. He is an experienced C-Suite professional who also holds an MBA from Duke University and is adept at crafting business as well as legal solutions. He brings a strong skillset in governance and public company readiness having been involved with SPAC and IPO transactions. His business acumen led to an appointment as the CEO of a multi-billion-dollar tech company before joining the iMedrix Board and he now serves as the General Counsel and Chief Administrative Officer of iMedrix Diagnostics.